Voyager Therapeutics, Inc. Revenue Breakdown
No Revenue Breakdown for VYGR on this site yet.
- 2025-12-31: Others Not split by product in the filing$40.37M100.00%; Total revenue $40.37M.
- 2024-12-31: Others Not split by product in the filing$80.00M100.00%; Total revenue $80.00M.
- 2023-12-31: Others Not split by product in the filing$250.01M100.00%; Total revenue $250.01M.
- 2022-12-31: Others Not split by product in the filing$40.91M100.00%; Total revenue $40.91M.
Source checked: the stored Revenue Breakdown page for VYGR.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $40.37M 100.00% | $40.37M |
| 2024-12-31 | Not split by product in the filing $80.00M 100.00% | $80.00M |
| 2023-12-31 | Not split by product in the filing $250.01M 100.00% | $250.01M |
| 2022-12-31 | Not split by product in the filing $40.91M 100.00% | $40.91M |
| 2021-12-31 | Not split by product in the filing $37.41M 100.00% | $37.41M |
| 2020-12-31 | Not split by product in the filing $171.13M 100.00% | $171.13M |
| 2019-12-31 | Not split by product in the filing $104.39M 100.00% | $104.39M |
| 2018-12-31 | Not split by product in the filing $7.62M 100.00% | $7.62M |
| 2017-12-31 | Not split by product in the filing $10.13M 100.00% | $10.13M |
| 2016-12-31 | Not split by product in the filing $14.22M 100.00% | $14.22M |
| 2015-12-31 | Not split by product in the filing $17.33M 100.00% | $17.33M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $3.17M 100.00% | $3.17M |
| 2026-03-31 | Not split by product $2.59M 100.00% | $2.59M |
| 2025-12-31 | Not split by product $15.34M 100.00% | $15.34M |
| 2025-09-30 | Not split by product $13.37M 100.00% | $13.37M |
| 2025-06-30 | Not split by product $5.20M 100.00% | $5.20M |
| 2025-03-31 | Not split by product $6.47M 100.00% | $6.47M |
| 2024-12-31 | Not split by product $6.28M 100.00% | $6.28M |
| 2024-09-30 | Not split by product $24.63M 100.00% | $24.63M |
| 2024-06-30 | Not split by product $29.58M 100.00% | $29.58M |
| 2024-03-31 | Not split by product $19.52M 100.00% | $19.52M |
| 2023-12-31 | Not split by product $90.06M 100.00% | $90.06M |
| 2023-09-30 | Not split by product $4.61M 100.00% | $4.61M |
| 2023-06-30 | Not split by product $4.85M 100.00% | $4.85M |
| 2023-03-31 | Not split by product $150.48M 100.00% | $150.48M |
| 2022-12-31 | Not split by product -$1.55M 100.00% | -$1.55M |
| 2022-09-30 | Not split by product $41.09M 100.00% | $41.09M |
| 2022-06-30 | Not split by product $712.00K 100.00% | $712.00K |
| 2022-03-31 | Not split by product $658.00K 100.00% | $658.00K |
| 2021-12-31 | Not split by product $28.07M 100.00% | $28.07M |
| 2021-09-30 | Not split by product $1.48M 100.00% | $1.48M |
| 2021-06-30 | Not split by product $1.36M 100.00% | $1.36M |
| 2021-03-31 | Not split by product $6.50M 100.00% | $6.50M |
| 2020-12-31 | Not split by product $6.54M 100.00% | $6.54M |
| 2020-09-30 | Not split by product $117.84M 100.00% | $117.84M |
| 2020-06-30 | Not split by product $28.68M 100.00% | $28.68M |
| 2020-03-31 | Not split by product $18.07M 100.00% | $18.07M |
| 2019-12-31 | Not split by product $32.67M 100.00% | $32.67M |
| 2019-09-30 | Not split by product $20.43M 100.00% | $20.43M |
| 2019-06-30 | Not split by product $46.09M 100.00% | $46.09M |
| 2019-03-31 | Not split by product $5.20M 100.00% | $5.20M |
| 2018-12-31 | Not split by product $2.01M 100.00% | $2.01M |
| 2018-09-30 | Not split by product $2.09M 100.00% | $2.09M |
| 2018-06-30 | Not split by product $2.58M 100.00% | $2.58M |
| 2018-03-31 | Not split by product $942.00K 100.00% | $942.00K |
| 2017-12-31 | Not split by product $6.35M 100.00% | $6.35M |
| 2017-09-30 | Not split by product $1.15M 100.00% | $1.15M |
| 2017-06-30 | Not split by product $1.18M 100.00% | $1.18M |
| 2017-03-31 | Not split by product $1.46M 100.00% | $1.46M |
| 2016-12-31 | Not split by product $2.36M 100.00% | $2.36M |
| 2016-09-30 | Not split by product $3.31M 100.00% | $3.31M |
| 2016-06-30 | Not split by product $3.72M 100.00% | $3.72M |
| 2016-03-31 | Not split by product $4.83M 100.00% | $4.83M |
| 2015-12-31 | Not split by product $4.94M 100.00% | $4.94M |
| 2015-09-30 | Not split by product $4.94M 100.00% | $4.94M |
| 2015-06-30 | Not split by product $4.88M 100.00% | $4.88M |
| 2015-03-31 | Not split by product $2.58M 100.00% | $2.58M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |